Pre-stroke use of statins on stroke outcome: a meta-analysis of observational studies

Ann Cordenier*, Ann De Smedt, Raf Brouns, Maarten Uyttenboogaart, Sylvie De Raedt, Gert-Jan Luijckx, Jacques De Keyser

*Bijbehorende auteur voor dit werk

    Onderzoeksoutputpeer review

    14 Citaten (Scopus)


    Background: Animal pre-clinical studies suggest that statins may have neuroprotective effects in acute ischaemic stroke. Statins might also increase the risk of developing haemorrhagic transformation after thrombolytic treatment.

    Methods: We performed a systematic review and included studies that compared good functional outcome, defined as a modified Rankin Scale (mRS) score

    Results: Eleven studies met our predefined inclusion criteria. Statin therapy before stroke-onset was associated with a lower risk of in-hospital mortality (OR 0.56; 95% CI: 0.40 to 0.78, P <0.0006). There was no difference between the two groups for good functional outcome at 3 months (OR 1.01; 95% CI: 0.64 to 1.61, P = 0.96). Statin use was associated with an increased risk of developing symptomatic haemorrhagic transformation after thrombolytic therapy (OR 2.34; 95% CI 1.31 to 4.17, P = 0.004).

    Conclusions: Our meta-analysis suggests that pretreatment with statins does not improve 3 months functional outcome, defined as independence on mRS, but decreases in-hospital mortality and increases the risk of developing a symptomatic haemorrhagic transformation in patients treated with thrombolysis.

    Originele taal-2English
    Pagina's (van-tot)261-267
    Aantal pagina's7
    TijdschriftActa neurologica belgica
    Nummer van het tijdschrift4
    StatusPublished - dec-2011

    Citeer dit